November 2006 Sosei Announces that QVA149 Clinical Development starts in 2007 and Updates the Status of NVA237 November 2006 Sosei Announces Results of AD 452 Phase IIb Clinical Trial November 2006 Sosei Announces Initiation of Phase I Trial for NorLevo® November 2006 Announcement of New Appointments November 2006 Summary of Consolidated Financial Results for the First Half Ended 30th September 2006 ( abridged English version ) November 2006 Revision Announcement of Financial Forecasts for FY2006 October 2006 Sosei Announces Start of Phase II Trial of AD 337 in Fibromyalgia Syndrome August 2006 Summary of Consolidated Financial Results for the First Quarter ended 30th June 2006 ( abridged English version ) June 2006 Sosei and Vectura Announce Successful Completion of Phase IIb Trial of NVA237 for COPD June 2006 Sosei Announces Agreement with Mundipharma for AD 923 Revision Announcement of Financial Forecast for FY2006 June 2006 Sosei Business Strategy Update and Portfolio Review May 2006 Consolidated Financial Results for the Fiscal Year Ended March 31, 2006 Sosei Announces Reorganization of its Corporate Structure under Holding Company Sosei Discontinues Development of SOU-001 Sosei Announces Company Name Change of two Affiliates May 2006 Revision Announcement of Financial Forecasts for FY2005 March 2006 Announcement of New Appointments March 2006 Sosei sells off its subsidiary, SC Consulting February 2006 Amendment of Consolidated Financial Results for 9 Months Ended 31 Dec. 2005 January 2006 Sosei updates the status of Eligard 2008 | 2007 | 2006 | 2005 | 2004